Luca Issi
Stock Analyst at RBC Capital
(0.26)
# 4,534
Out of 5,005 analysts
698
Total ratings
36.4%
Success rate
-3.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Initiated Coverage: Buy | $18 | $7.28 | +147.25% | 1 | Sep 16, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $35 → $30 | $16.34 | +83.60% | 13 | Sep 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgraded: Hold | $40 → $19 | $14.41 | +31.85% | 21 | Sep 3, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $100 | $65.46 | +52.77% | 41 | Aug 30, 2026 | |
| MRNA Moderna | Reiterated: Hold | $45 → $130 | $197.28 | -34.10% | 40 | Aug 19, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,025 → $1,100 | $972.25 | +13.14% | 13 | Aug 17, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $100 | $66.61 | +50.13% | 5 | Aug 14, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $280 → $290 | $230.05 | +26.06% | 17 | Aug 13, 2026 | |
| CRBU Caribou Biosciences | Reiterated: Buy | $10 | $1.23 | +713.01% | 23 | Aug 13, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $9 | $1.63 | +452.15% | 33 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.14 | +536.94% | 15 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 | $59.46 | +4.27% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $10 | $9.51 | +5.15% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $11.42 | +31.35% | 37 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $7.47 | +154.35% | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $400 | $418.13 | -4.34% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $24.23 | +7.30% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.51 | +59.36% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $54.09 | -7.56% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $33.42 | -4.25% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $445 → $350 | $255.36 | +37.06% | 65 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.67 | +308.72% | 28 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $45.57 | +86.53% | 41 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $39.11 | +66.20% | 44 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $4 | $3.72 | +7.53% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.141 | +1,318.44% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $11.11 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $54 | $9.23 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $3.96 | n/a | 7 | Mar 21, 2023 |
Solid Biosciences
Sep 16, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $7.28
Upside: +147.25%
Dyne Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $35 → $30
Current: $16.34
Upside: +83.60%
Ultragenyx Pharmaceutical
Sep 3, 2026
Downgraded: Hold
Price Target: $40 → $19
Current: $14.41
Upside: +31.85%
Arrowhead Pharmaceuticals
Aug 30, 2026
Reiterated: Buy
Price Target: $100
Current: $65.46
Upside: +52.77%
Moderna
Aug 19, 2026
Reiterated: Hold
Price Target: $45 → $130
Current: $197.28
Upside: -34.10%
argenx SE
Aug 17, 2026
Reiterated: Buy
Price Target: $1,025 → $1,100
Current: $972.25
Upside: +13.14%
BridgeBio Pharma
Aug 14, 2026
Reiterated: Buy
Price Target: $100
Current: $66.61
Upside: +50.13%
Ascendis Pharma
Aug 13, 2026
Reiterated: Buy
Price Target: $280 → $290
Current: $230.05
Upside: +26.06%
Caribou Biosciences
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.23
Upside: +713.01%
Allogene Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $9
Current: $1.63
Upside: +452.15%
Aug 12, 2026
Reiterated: Buy
Price Target: $20
Current: $3.14
Upside: +536.94%
Aug 7, 2026
Reiterated: Hold
Price Target: $62
Current: $59.46
Upside: +4.27%
Aug 7, 2026
Reiterated: Hold
Price Target: $8 → $10
Current: $9.51
Upside: +5.15%
Aug 6, 2026
Reiterated: Hold
Price Target: $15
Current: $11.42
Upside: +31.35%
Aug 6, 2026
Reiterated: Buy
Price Target: $19
Current: $7.47
Upside: +154.35%
Aug 5, 2026
Reiterated: Buy
Price Target: $370 → $400
Current: $418.13
Upside: -4.34%
Aug 5, 2026
Reiterated: Hold
Price Target: $26
Current: $24.23
Upside: +7.30%
Aug 5, 2026
Reiterated: Hold
Price Target: $4
Current: $2.51
Upside: +59.36%
Aug 3, 2026
Reiterated: Hold
Price Target: $50
Current: $54.09
Upside: -7.56%
Jul 30, 2026
Reiterated: Hold
Price Target: $32
Current: $33.42
Upside: -4.25%
Jul 30, 2026
Rated: Buy
Price Target: $445 → $350
Current: $255.36
Upside: +37.06%
Jul 30, 2026
Reiterated: Buy
Price Target: $15
Current: $3.67
Upside: +308.72%
Jul 29, 2026
Reiterated: Buy
Price Target: $85
Current: $45.57
Upside: +86.53%
Jul 29, 2026
Reiterated: Buy
Price Target: $65
Current: $39.11
Upside: +66.20%
Jun 2, 2026
Reiterated: Hold
Price Target: $10 → $4
Current: $3.72
Upside: +7.53%
May 14, 2026
Reiterated: Hold
Price Target: $2
Current: $0.141
Upside: +1,318.44%
Nov 13, 2024
Reiterated: Buy
Price Target: $9 → $11
Current: $11.11
Upside: n/a
May 11, 2023
Reiterated: Hold
Price Target: $3 → $54
Current: $9.23
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: $4 → $3
Current: $3.96
Upside: n/a